MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    PET and Clinical Evidence for Neuroprotective Effects of KM-819 on MSA

    C. Lee, C. Barlow, E. Kim, D. Kim, D. Doudet, J. Ko, M. Goh (Seongnam-si, Gyeonggi-do, Republic of Korea)

    Objective: To assess the effect of KM-819 on the progression of multiple system atrophy (MSA). Background: Parkinson’s brain is associated with increased expression of the…
  • 2025 International Congress

    Relationship Between Alpha-Synuclein Aggregation Profiles, Imaging Biomarkers, and Disease Severity in a Phase 2 Study of ATH434 in MSA

    M. Bradbury, P. Trujillo, K. Hett, C. Wong, C. Lucas, K. Kmiecik, D. Stamler, D. Claassen (Newark, USA)

    Objective: To investigate the relationships between α-synuclein aggregation profiles, imaging biomarkers, and UMSARS I scores in the ATH434-201 Phase 2 study. Background: Multiple system atrophy…
  • 2025 International Congress

    Disease Characteristics of the First 100 Participants in the CurePSP Genetics Program Cohort

    C. Obasi, V. Zhao, C. Martinez, S. Scholz, H. Morris, N. Mcfarland, M. Nance, J. Wang, N. Mencacci, B. Cuoto, T. Foroud, J. Verbrugge, A. Miller, L. Heathers, L. Honig, A. Lang, F. Rodriguez-Porcel, P. Moretti, M. Mesaros, J. Brummet, K. Diaz, A. Wills (Boston, USA)

    Objective: To increase our understanding of the pathogenesis of atypical parkinsonian disorders though genetics, and to build a cohort of individuals for future research. Background:…
  • 2025 International Congress

    Natural history and epidemiological study of multiple system atrophy in Hokkaido: HoRC-MSA 2014-2025

    M. Matsushima, K. Sakushima, Y. Kanatani, N. Nishimoto, J. Sawada, T. Matsuoka, H. Uesugi, N. Minami, K. Sako, A. Takei, S. Hisahara, A. Tamakoshi, N. Sato, I. Yabe (Sapporo, Japan)

    Objective: To investigate epidemiological information of multiple system atrophy (MSA) patients in Hokkaido, Japan by using the registry data from the Hokkaido Rare-disease Consortium for…
  • 2025 International Congress

    Changes in Inhibitory Control Differentiate Progressive Supranuclear Palsy from Early Parkinson’s Disease

    B. Couto, F. Castano, J. Carrillo, M. Roca, A. Chade, O. Gershanik, G. Gomez-Arevalo (Buenos Aires, Argentina)

    Objective: To describe distinct type of errors and frequency of perseverative errors in executive, memory, language, and attentional tasks in PSP and PD. Background: Progressive…
  • 2025 International Congress

    Interlaboratory cross-validation of CSF α-synuclein seeding aggregation assay for parkinsonisms

    J. Perez-Montesino, M. Fernandez, R. Ruiz-Garcia, L. Naranjo, C. Painous, A. Camara, A. Perez-Soriano, L. de Mena, Y. Compta (Barcelona, Spain)

    Objective: To evaluate CSF α-syn-SAA interlaboratory reproducibility in diagnosing Parkinson´s Disease (PD) and atypical parkinsonisms as well as interrogate the effect of changes in lot…
  • 2025 International Congress

    Examining Disparities and Device Usage in Outpatient Telemedicine Visits Amongst Movement Disorders Patients

    V. Palakuzhy, B. Ouyang, G. Stebbins, C. Goetz, M. Afshari (Chicago, USA)

    Objective: To characterize trends in device usage (mobile-device vs. personal computer (PC)) across demographic factors for video-based telemedicine visits in an urban tertiary Movement Disorders…
  • 2025 International Congress

    Analysis of Diagnostic Outcomes and Imaging Features in Patients with Ventriculomegaly and Gait Impairment

    C. Espinoza-Vinces, I. Avilés-Olmos, J. Núñez Córdoba, M. Jiménez Vázquez, M. Calvo Imirizaldu, G. Martí-Andrés, M. Luquin (Pamplona, Spain)

    Objective: To describe the clinical features, diagnostic outcomes, and brain MRI imaging characteristics in patients with ventriculomegaly and gait impairment Background: Emerging evidence suggests that ventriculomegaly,…
  • 2025 International Congress

    Loneliness accelerates parkinsonism decline in parkinsonian community-dwelling older adults

    D. Gonzalez, M. Wilson, M. Tosin, M. Roy, C. Goetz (Chicago, USA)

    Objective: To determine the longitudinal impact of loneliness on parkinsonism, relative to the longitudinal impact of parkinsonism on loneliness, in parkinsonian adults. Background: The link…
  • 2025 International Congress

    Exploring The Correlation of Neuroimaging, Molecular and Electrophysiological Biomarkers in Patients with Progressive Supranuclear Palsy – Richardson Type

    S. Mondal, B. Biswas, R. Banerjee, S. Choudhury, K. Chatterjee, J. Rungta, S. Sengupta, A. Bayen, P. Basu, E. Basu, S. Dasgupta, G. Ahmed, J. Ganguly, M. Tiwari, H. Kumar (Kolkata, India)

    Objective: To correlate blood and electrophysiological biomarkers in Progressive Supranuclear Palsy – Richardson’s type (PSP-RS) patients with brain structural alterations using neuromorphometry. Background: Various biomarkers, including…
  • « Previous Page
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley